You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
- 2. Kexing Biopharm's New Cancer Drug Gets Peru Market Approval
- 3. Early prediction of colorectal adenoma risk: leveraging large-language model for clinical electronic medical record data
- 4. IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis
- 5. Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape
- 6. Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer
- 7. NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
- 8. Visualising the mechanics of hormone-driven gene activation: Insights into breast cancer
- 9. Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy: a rare case report
- 10. A simple approach to prevent skin damage from heat steam in robotic breast surgery
Last updated at 13:06 GMT
Hot News Makers
Health/Pharma Companies
-
12219.57
-
6872.00
-
3364.35
-
3048.23
-
3033.98
-
2615.63
-
1884.24
-
1231.19
-
753.18
-
597.76
Drugs, Treatments, Trials
-
2178.11
-
1876.82
-
1452.08
-
1225.09
-
618.97
-
450.49
-
368.85
-
261.86
-
151.21
-
110.26
Last updated at 12:10 GMT
